Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1988 Apr;69(2):157–167.

Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.

J Kocsis 1, G Karácsony 1, S Karcsú 1, F A László 1
PMCID: PMC2013217  PMID: 3377960

Abstract

Bilateral renal cortical necrosis was observed after vasopressin administration in rats pretreated with oestrone acetate. Histochemical (succinic dehydrogenase, trichrome, periodic acid Schiff) and electronmicroscopic methods were used to examine how the anti-oestrogen, Tamoxifen, influences the development of this renal cortical necrosis. The experiments revealed that in most rats vasopressin did not induce renal tubular necrosis if the anti-oestrogen was administered simultaneously, even during oestrogen pretreatment. The results suggest that oestrogen receptors in the kidney are involved in the induction of renal cortical necrosis by vasopressin.

Full text

PDF
157

Images in this article

162Fig. 5
on p.162
163Fig. 5
on p.163
161Fig. 3
on p.161
161Fig. 4
on p.161
159Fig. 1
on p.159
160Fig. 2
on p.160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BYROM F. B., PRATT O. E. Oxytocin and renal cortical necrosis. Lancet. 1959 Apr 11;1(7076):753–754. doi: 10.1016/s0140-6736(59)91827-6. [DOI] [PubMed] [Google Scholar]
  2. Bloom H. J., Boesen E. Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. Br Med J. 1974 Apr 6;2(5909):7–10. doi: 10.1136/bmj.2.5909.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borgna J. L., Coezy E., Rochefort H. Mode of action of LN 1643 (a triphenylbromoethylene antiestrogen): probable mediation by the estrogen receptor and high affinity metabolite. Biochem Pharmacol. 1982 Oct 15;31(20):3187–3191. doi: 10.1016/0006-2952(82)90548-2. [DOI] [PubMed] [Google Scholar]
  4. Borgna J. L., Rochefort H. High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metabolite. Mol Cell Endocrinol. 1980 Oct;20(1):71–85. doi: 10.1016/0303-7207(80)90095-7. [DOI] [PubMed] [Google Scholar]
  5. Capony F., Rochefort H. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor. Mol Cell Endocrinol. 1978 Jul-Aug;11(2):181–198. doi: 10.1016/0303-7207(78)90006-0. [DOI] [PubMed] [Google Scholar]
  6. Clark J. H., Anderson J. N., Peck E. J., Jr Estrogen receptor-anti-estrogen complex: atypical binding by uterine nuclei and effects on uterine growth. Steroids. 1973 Nov;22(5):707–718. doi: 10.1016/0039-128x(73)90118-9. [DOI] [PubMed] [Google Scholar]
  7. Clark J. H., Peck E. J., Jr, Anderson J. N. Oestrogen receptors and antagonism of steroid hormone action. Nature. 1974 Oct 4;251(5474):446–448. doi: 10.1038/251446a0. [DOI] [PubMed] [Google Scholar]
  8. Cole M. P., Jones C. T., Todd I. D. A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer. 1971 Jun;25(2):270–275. doi: 10.1038/bjc.1971.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DEIS R. P., LLOYD S., PICKFORD M. The effects of stiboestrol and progesterone, and of renal denervation on the response of the kidneys to vasopressin and oxytocin. J Physiol. 1963 Feb;165:348–357. doi: 10.1113/jphysiol.1963.sp007061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Deutsch V., Frankl O., Drory Y., Eliahou H., Braf Z. F. Bilateral renal cortical necrosis with survival through the acute phase with a note on the value of selective nephroangiography. Am J Med. 1971 Jun;50(6):828–834. doi: 10.1016/0002-9343(71)90192-6. [DOI] [PubMed] [Google Scholar]
  11. Eckert R. L., Katzenellenbogen B. S. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res. 1982 Jan;42(1):139–144. [PubMed] [Google Scholar]
  12. Edgren R. A., Jones R. C., Peterson D. L., Gillen A. L. Studies on the interactions of ethynyl oestradiol and norgestrel. Acta Endocrinol (Copenh) 1967;54(Suppl):3–21. [PubMed] [Google Scholar]
  13. FOLCA P. J., GLASCOCK R. F., IRVINE W. T. Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy. Lancet. 1961 Oct 7;2(7206):796–798. doi: 10.1016/s0140-6736(61)91088-1. [DOI] [PubMed] [Google Scholar]
  14. Feherty P., Farrer-Brown G., Kellie A. E. Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay. Br J Cancer. 1971 Dec;25(4):697–710. doi: 10.1038/bjc.1971.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. GREENBLATT R. B., BARFIELD W. E., JUNGCK E. C., RAY A. W. Induction of ovulation with MRL/41. Preliminary report. JAMA. 1961 Oct 14;178:101–104. doi: 10.1001/jama.1961.03040410001001. [DOI] [PubMed] [Google Scholar]
  16. GREENBLATT R. B., ROY S., MAHESH V. B., BARFIELD W. E., JUNGCK E. C. Induction of ovulation. Am J Obstet Gynecol. 1962 Oct 1;84:900–912. [PubMed] [Google Scholar]
  17. Hiault C., Dequiedt P., Benoit O., Dognin C., Monnier J. C., Cotteel M., Puech F., Leroy J. L., Tacquet A., Delecour M. La nécrose corticale rénale du post-partum. J Gynecol Obstet Biol Reprod (Paris) 1982;11(7):839–848. [PubMed] [Google Scholar]
  18. Hähnel R., Twaddle E., Ratajczak T. The influence of synthetic anti-estrogens on the binding of tritiated estradiol-17beta by cytosols of human uterus and human breast carcinoma. J Steroid Biochem. 1973 Nov;4(6):687–695. doi: 10.1016/0022-4731(73)90044-7. [DOI] [PubMed] [Google Scholar]
  19. Jensen E. V., Block G. E., Smith S., Kyser K., DeSombre E. R. Estrogen receptors and breast cancer response to adrenalectomy. Natl Cancer Inst Monogr. 1971 Dec;34:55–70. [PubMed] [Google Scholar]
  20. Johnson J. A., Davis J. O., Baumber J. S., Schneider E. G. Effects of estrogens and progesterone on electrolyte balances in normal dogs. Am J Physiol. 1970 Dec;219(6):1691–1697. doi: 10.1152/ajplegacy.1970.219.6.1691. [DOI] [PubMed] [Google Scholar]
  21. Jordan V. C., Dix C. J., Rowsby L., Prestwich G. Studies on the mechanism of action of the nonsteroidal antioestrogen tamoxifen (I.C.I. 46,474) in the rat. Mol Cell Endocrinol. 1977 Apr;7(2):177–192. doi: 10.1016/0303-7207(77)90066-1. [DOI] [PubMed] [Google Scholar]
  22. Katzenellenbogen B. S., Katzenellenbogen J. A., Ferguson E. R., Krauthammer N. Anti-estrogen interaction with uterine estrogen receptors. Studies with a radiolabeled anti-estrogen (CI-628). J Biol Chem. 1978 Feb 10;253(3):697–707. [PubMed] [Google Scholar]
  23. Kocsis J., Karácsony G., Karcsú S., László F. A. Histochemical and ultrastructural study of renal cortical necrosis in rats treated with oestrone + vasopressin, and its prevention with a vasopressin antagonist. Br J Exp Pathol. 1987 Feb;68(1):35–43. [PMC free article] [PubMed] [Google Scholar]
  24. Korenman S. G., Dukes B. A. Specific estrogen binding by the cytoplasm fof human breast carcinoma. J Clin Endocrinol Metab. 1970 May;30(5):639–645. doi: 10.1210/jcem-30-5-639. [DOI] [PubMed] [Google Scholar]
  25. LLOYD S. Changes in the vascular responses of the rat during pregnancy. J Physiol. 1959 Dec;149:586–592. doi: 10.1113/jphysiol.1959.sp006362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Leclercq G., Heuson J. C., Schoenfeld R., Mattheiem W. H., Tagnon H. J. Estrogen receptors in human breast cancer. Eur J Cancer. 1973 Sep;9(9):665–673. doi: 10.1016/0014-2964(73)90009-1. [DOI] [PubMed] [Google Scholar]
  27. Lippman M. E., Bolan G. Oestrogen-responsive human breast cancer in long term tissue culture. Nature. 1975 Aug 14;256(5518):592–593. doi: 10.1038/256592a0. [DOI] [PubMed] [Google Scholar]
  28. McCall A. L., Stern J., Dale S. L., Melby J. C. Adrenal steroidogenesis in methylandrostenediol-induced hypertension. Endocrinology. 1978 Jul;103(1):1–5. doi: 10.1210/endo-103-1-1. [DOI] [PubMed] [Google Scholar]
  29. McGuire W. L., Chamness G. C., Costlow M. E., Shepherd R. E. Hormone dependence in breast cancer. Metabolism. 1974 Jan;23(1):75–100. doi: 10.1016/0026-0495(74)90106-1. [DOI] [PubMed] [Google Scholar]
  30. Pasqualini J. R., Sumida C., Gelly C., Bach-Lien Nguyen Formation de complexes 3H-oestradiol-macromolécules dans les fractions cytosoliques et nucléaires du tissu rénal du foetus de cobaye. C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 18;276(25):3359–3362. [PubMed] [Google Scholar]
  31. Sander S. In vitro uptake of oestradiol in DMBA induced breast tumours of the rat. Acta Pathol Microbiol Scand. 1969;75(4):520–526. [PubMed] [Google Scholar]
  32. Skidmore J., Walpole A. L., Woodburn J. Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary. J Endocrinol. 1972 Feb;52(2):289–298. doi: 10.1677/joe.0.0520289. [DOI] [PubMed] [Google Scholar]
  33. Terenius L. Anti-oestrogens and breast cancer. Eur J Cancer. 1971 Feb;7(1):57–64. doi: 10.1016/0014-2964(71)90095-8. [DOI] [PubMed] [Google Scholar]
  34. Westley B., Rochefort H. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 1980 Jun;20(2):353–362. doi: 10.1016/0092-8674(80)90621-2. [DOI] [PubMed] [Google Scholar]
  35. Westley B., Rochefort H. Estradiol induced proteins in the MCF7 human breast cancer cell line. Biochem Biophys Res Commun. 1979 Sep 27;90(2):410–416. doi: 10.1016/0006-291x(79)91250-6. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES